Global and United States Long Acting Insulins Market Report & Forecast 2023-2028

Report ID: 1873729 | Published Date: Jan 2025 | No. of Page: 70 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
1 Study Coverage
    1.1 Long Acting Insulins Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Long Acting Insulins Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Long Acting Insulins Market Size for the Year 2017-2028
        1.2.2 Global Long Acting Insulins Market Size for the Year 2017-2028
    1.3 Long Acting Insulins Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Long Acting Insulins in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Long Acting Insulins Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Long Acting Insulins Market Dynamics
        1.4.1 Long Acting Insulins Industry Trends
        1.4.2 Long Acting Insulins Market Drivers
        1.4.3 Long Acting Insulins Market Challenges
        1.4.4 Long Acting Insulins Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Long Acting Insulins by Type
    2.1 Long Acting Insulins Market Segment by Type
        2.1.1 Insulin Glargine
        2.1.2 Insulin Determir
        2.1.3 Insulin Degludec
        2.1.4 Long Acting Animal Insulin
    2.2 Global Long Acting Insulins Market Size by Type (2017, 2022 & 2028)
    2.3 Global Long Acting Insulins Market Size by Type (2017-2028)
    2.4 United States Long Acting Insulins Market Size by Type (2017, 2022 & 2028)
    2.5 United States Long Acting Insulins Market Size by Type (2017-2028)
3 Long Acting Insulins by Application
    3.1 Long Acting Insulins Market Segment by Application
        3.1.1 Home Use
        3.1.2 Medical Institutions
        3.1.3 Others
    3.2 Global Long Acting Insulins Market Size by Application (2017, 2022 & 2028)
    3.3 Global Long Acting Insulins Market Size by Application (2017-2028)
    3.4 United States Long Acting Insulins Market Size by Application (2017, 2022 & 2028)
    3.5 United States Long Acting Insulins Market Size by Application (2017-2028)
4 Global Long Acting Insulins Competitor Landscape by Company
    4.1 Global Long Acting Insulins Market Size by Company
        4.1.1 Top Global Long Acting Insulins Companies Ranked by Revenue (2021)
        4.1.2 Global Long Acting Insulins Revenue by Player (2017-2022)
    4.2 Global Long Acting Insulins Concentration Ratio (CR)
        4.2.1 Long Acting Insulins Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Long Acting Insulins in 2021
        4.2.3 Global Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Long Acting Insulins Headquarters, Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Long Acting Insulins Headquarters and Area Served
        4.3.2 Global Long Acting Insulins Companies Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Long Acting Insulins Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Long Acting Insulins Market Size by Company
        4.5.1 Top Long Acting Insulins Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Long Acting Insulins Revenue by Players (2020, 2021 & 2022)
5 Global Long Acting Insulins Market Size by Region
    5.1 Global Long Acting Insulins Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Long Acting Insulins Market Size by Region (2017-2028)
        5.2.1 Global Long Acting Insulins Market Size by Region: 2017-2022
        5.2.2 Global Long Acting Insulins Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Long Acting Insulins Market Size YoY Growth 2017-2028
        6.1.2 North America Long Acting Insulins Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Long Acting Insulins Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Long Acting Insulins Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Long Acting Insulins Market Size YoY Growth 2017-2028
        6.3.2 Europe Long Acting Insulins Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Long Acting Insulins Market Size YoY Growth 2017-2028
        6.4.2 Latin America Long Acting Insulins Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Long Acting Insulins Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Long Acting Insulins Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Novo Nordisk
        7.1.1 Novo Nordisk Company Details
        7.1.2 Novo Nordisk Business Overview
        7.1.3 Novo Nordisk Long Acting Insulins Introduction
        7.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2017-2022)
        7.1.5 Novo Nordisk Recent Development
    7.2 Sanofi
        7.2.1 Sanofi Company Details
        7.2.2 Sanofi Business Overview
        7.2.3 Sanofi Long Acting Insulins Introduction
        7.2.4 Sanofi Revenue in Long Acting Insulins Business (2017-2022)
        7.2.5 Sanofi Recent Development
    7.3 Wockhardt UK
        7.3.1 Wockhardt UK Company Details
        7.3.2 Wockhardt UK Business Overview
        7.3.3 Wockhardt UK Long Acting Insulins Introduction
        7.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2017-2022)
        7.3.5 Wockhardt UK Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. Long Acting Insulins Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Long Acting Insulins Market Trends
    Table 3. Long Acting Insulins Market Drivers
    Table 4. Long Acting Insulins Market Challenges
    Table 5. Long Acting Insulins Market Restraints
    Table 6. Global Long Acting Insulins Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Long Acting Insulins Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Long Acting Insulins Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Long Acting Insulins Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Long Acting Insulins Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Long Acting Insulins Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Long Acting Insulins Revenue Share by Player, 2017-2022
    Table 13. Global Long Acting Insulins Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Long Acting Insulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Insulins as of 2021)
    Table 15. Top Players of Long Acting Insulins in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Long Acting Insulins Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Long Acting Insulins Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Long Acting Insulins Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Long Acting Insulins Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Long Acting Insulins Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Long Acting Insulins Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Long Acting Insulins Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Long Acting Insulins Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Long Acting Insulins Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Long Acting Insulins Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Long Acting Insulins Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Long Acting Insulins Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Novo Nordisk Company Details
    Table 31. Novo Nordisk Business Overview
    Table 32. Novo Nordisk Long Acting Insulins Product
    Table 33. Novo Nordisk Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million)
    Table 34. Novo Nordisk Recent Development
    Table 35. Sanofi Company Details
    Table 36. Sanofi Business Overview
    Table 37. Sanofi Long Acting Insulins Product
    Table 38. Sanofi Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million)
    Table 39. Sanofi Recent Development
    Table 40. Wockhardt UK Company Details
    Table 41. Wockhardt UK Business Overview
    Table 42. Wockhardt UK Long Acting Insulins Product
    Table 43. Wockhardt UK Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million)
    Table 44. Wockhardt UK Recent Development
    Table 45. Research Programs/Design for This Report
    Table 46. Key Data Information from Secondary Sources
    Table 47. Key Data Information from Primary Sources
List of Figures
    Figure 1. Long Acting Insulins Product Picture
    Figure 2. Global Long Acting Insulins Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Long Acting Insulins Market Size 2017-2028 (US$ Million)
    Figure 4. United States Long Acting Insulins Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Long Acting Insulins Market Size 2017-2028 (US$ Million)
    Figure 6. United States Long Acting Insulins Market Share in Global 2017-2028
    Figure 7. Long Acting Insulins Report Years Considered
    Figure 8. Product Picture of Insulin Glargine
    Figure 9. Product Picture of Insulin Determir
    Figure 10. Product Picture of Insulin Degludec
    Figure 11. Product Picture of Long Acting Animal Insulin
    Figure 12. Global Long Acting Insulins Market Share by Type in 2022 & 2028
    Figure 13. Global Long Acting Insulins Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Long Acting Insulins Market Share by Type (2017-2028)
    Figure 15. United States Long Acting Insulins Market Share by Type in 2022 & 2028
    Figure 16. United States Long Acting Insulins Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Long Acting Insulins Market Share by Type (2017-2028)
    Figure 18. Product Picture of Home Use
    Figure 19. Product Picture of Medical Institutions
    Figure 20. Product Picture of Others
    Figure 21. Global Long Acting Insulins Market Share by Application in 2022 & 2028
    Figure 22. Global Long Acting Insulins Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Long Acting Insulins Market Share by Application (2017-2028)
    Figure 24. United States Long Acting Insulins Market Share by Application in 2022 & 2028
    Figure 25. United States Long Acting Insulins Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Long Acting Insulins Market Share by Application (2017-2028)
    Figure 27. North America Long Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Long Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Long Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Long Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Long Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Long Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Novo Nordisk Revenue Growth Rate in Long Acting Insulins Business (2017-2022)
    Figure 56. Sanofi Revenue Growth Rate in Long Acting Insulins Business (2017-2022)
    Figure 57. Wockhardt UK Revenue Growth Rate in Long Acting Insulins Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novo Nordisk
Sanofi
Wockhardt UK
Frequently Asked Questions
Long Acting Insulins report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Long Acting Insulins report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Long Acting Insulins report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Premix Insulin

Premix Insulin market is segmented by region (country), players, by Type and by Application. Play ... Read More

Animal Insulin

Animal Insulin market is segmented by region (country), players, by Type and by Application. Play ... Read More